Doxorubicinhydrochlorid Teva® 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Sponsors
GPOH gGmbH, Takeda Development Center Americas Inc.
Conditions
Advanced Classical Hodgkin Lymphomaatypical teratoid/rhabdoid tumours (ATRT)
Phase 3
An international prospective umbrella trial for children with atypical teratoid/rhabdoid tumours (ATRT) including a randomized phase III study evaluating the non-inferiority of three courses of high-dose chemotherapy (HDCT) compared to focal radiotherapy as consolidation therapy
RecruitingCTIS2022-501456-28-00
Start: 2020-07-20Target: 301Updated: 2025-10-03
A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma
Active, not recruitingCTIS2023-506419-16-00
Start: 2013-01-08Target: 448Updated: 2025-12-15